Name | (2S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid |
---|---|
Synonyms |
Fmoc-Ser(2-acetamido-3,4,6,-tri-O-acetyl-2-deoxy-|A-D-galactopyranosyl)-OH
Fmoc-L-Tnser-OH N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-|A-D-galactopyranosyl]-L-serine N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-|A-D-galactopyranosyl]-L-serine N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-Alpha-D-galactopyranosyl]-L-serine Fmoc-Ser-(Ac3AcNH-|A-Gal)-OH Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH |
Description | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is a drug for cancer. |
---|---|
Related Catalog | |
References |
Molecular Formula | C32H36N2O13 |
---|---|
Molecular Weight | 656.63400 |
Exact Mass | 656.22200 |
PSA | 202.09000 |
LogP | 2.43280 |
Storage condition | -15°C |
RIDADR | NONH for all modes of transport |
---|
Precursor 7 | |
---|---|
DownStream 0 |